v3.26.1
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Operating activities:        
Net income (loss) $ 1,918 $ 654 $ 4,881 $ (3,260)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 9,995 7,409 19,949 14,287
Stock-based compensation expense 11,875 16,230 25,429 33,455
Amortization of deferred financing costs 132 62 566 124
Loss on extinguishment of debt 0 0 17 0
Cost of Phreesia hardware purchased by customers 245 157 433 593
Deferred contract acquisition costs amortization 108 242 224 352
Non-cash operating lease expense 564 218 797 433
Deferred taxes 1,136 (1,583) 1,813 (1,498)
Gains and losses for fair value option 2,812 0 2,812 0
Changes in operating assets and liabilities:        
Accounts receivable 185 (1,820) 7,916 (3,310)
Cash received for sale of receivables 995 0 8,706 0
Accrued interest receivable (12) 0 117 0
Prepaid expenses and other assets (2,640) (2,660) (1,812) (2,916)
Deferred contract acquisition costs 0 (351) 0 (351)
Accounts payable 489 2,068 648 329
Accrued expenses and other liabilities 4,982 (1,289) (2,003) (2,180)
Payment of due to provider for receivables sold to securitization (8,480) 0 (13,540) 0
Lease liabilities (452) (238) (862) (490)
Deferred revenue (5,524) (4,264) (13,841) (5,883)
Net cash provided by operating activities 18,328 14,835 42,250 29,685
Investing activities:        
Collections of cardholder receivables held for investment and deferred purchase price 26,672 0 39,024 0
Capitalized internal-use software (4,012) (3,435) (7,252) (7,323)
Purchases of property and equipment (492) (1,767) (4,802) (5,271)
Net cash provided by (used in) investing activities 22,168 (5,202) 26,970 (12,594)
Financing activities:        
Proceeds from issuance of common stock upon exercise of stock options 10 114 141 242
Treasury stock to satisfy tax withholdings on stock compensation awards (14) 0 (1,109) 0
Proceeds from employee stock purchase plan 236 575 758 1,343
Finance lease payments (1,188) (2,510) (2,868) (3,886)
Principal payments on financing agreements (364) (328) (719) (648)
Debt issuance costs and loan facility fee payments 0 0 (2,259) (38)
Debt extinguishment costs 0 0 (42) 0
Proceeds from debt instruments 0 0 92,240 0
Principal payments on debt instruments (23,500) 0 (121,500) 0
Payments due to provider for unfunded receivables (17,462) 0 (33,017) 0
Net cash used in financing activities (42,282) (2,149) (68,375) (2,987)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 25 (89) (39) (58)
Net (decrease) increase in cash, cash equivalents and restricted cash (1,761) 7,395 806 14,046
Cash, cash equivalents and restricted cash – beginning of period 76,397 90,871 73,830 84,220
Cash, cash equivalents and restricted cash – end of period 74,636 98,266 74,636 98,266
Supplemental information of non-cash investing and financing information:        
Non-cash activity related to credit card receivables and deferred purchase price 20,992 0 48,709 0
Exchange of right of use asset for property and equipment 0 0 57 0
Purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities 2,140 2,461 2,140 2,461
Capitalized stock-based compensation 238 320 580 652
Issuance of stock to settle liabilities for stock-based compensation 919 1,346 8,972 7,854
Cash paid for:        
Interest 703 330 4,551 654
Income taxes 2,884 763 4,065 1,314
Reconciliation of cash, cash equivalents and restricted cash shown in statements of cash flows        
Cash, cash equivalents and restricted cash per balance sheets 72,945 98,266 72,945 98,266
Restricted cash included in other long-term assets 1,691 0 1,691 0
Total cash, cash equivalents and restricted cash shown in statements of cash flows $ 74,636 $ 98,266 $ 74,636 $ 98,266